Design and Synthesis of Small Molecule Probes of MDA-9/Syntenin.
PDZ domain
anti-cancer agents
molecular modeling
protein–protein interactions
small molecule inhibitors
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
12 Oct 2024
12 Oct 2024
Historique:
received:
29
08
2024
revised:
30
09
2024
accepted:
09
10
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
26
10
2024
Statut:
epublish
Résumé
MDA-9/Syntenin, a key scaffolding protein and a molecular hub involved in a diverse range of cell signaling responses, has proved to be a challenging target for the design and discovery of small molecule probes. In this paper, we report on the design and synthesis of small molecule ligands of this key protein. Genetic algorithm-based computational design and the five-eight step synthesis of three molecules led to ligands with affinities in the range of 1-3 µM, a 20-60-fold improvement over literature reports. The design and synthesis strategies, coupled with the structure-dependent gain or loss in affinity, afford the deduction of principles that should guide the design of advanced probes of MDA-9/Syntenin.
Identifiants
pubmed: 39456220
pii: biom14101287
doi: 10.3390/biom14101287
pii:
doi:
Substances chimiques
Ligands
0
Syntenins
0
Small Molecule Libraries
0
Molecular Probes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : CA241951
Pays : United States
Organisme : National Heart, Lung and Blood Institute
ID : HL141954
Organisme : National Heart, Lung and Blood Institute
ID : HL181613
Organisme : NCI NIH HHS
ID : CA244993
Pays : United States
Organisme : NCI NIH HHS
ID : CA259599
Pays : United States